期刊文献+

紫杉醇超饱和自微乳化给药系统的制备及大鼠体内药动学研究

Preparation of paclitaxel supersaturatable self-microemulsifying drug delivery system and its pharmacokinetics in rats
下载PDF
导出
摘要 目的:制备紫杉醇超饱和自微乳化给药系统(supersaturatable self-microemulsifying drug delivery system,S-SMEDDS),并对其在大鼠体内的药动学进行研究。方法:采用伪三元相图的方法,优化紫杉醇自微乳化给药系统(SMEDDS)的处方。18只大鼠随机分为3组,分别灌胃给予10 mg/kg紫杉醇溶液、SMEDDS和S-SMEDDS,测定紫杉醇的血药浓度c、max、AUC和tmax,计算相对生物利用度。结果:确定紫杉醇SMEDDS最优处方为:油相∶表面活性剂∶助表面活性剂=50∶33∶17。油相为Lauroglycol FCC∶橄榄油(2∶1),表面活性剂为Cremophor EL∶吐温-80(1∶1),助表面活性剂为PEG-400。S-SMEDDS在此处方基础上添加5%羟丙基甲基纤维素。稀释对制剂的粒径无显著影响。SMEDDS和S-SMEDDS的粒径分别为(92.7±47.7)和(93.6±36.8)nm,粒径分布呈高斯分布。SMEDDS和S-SMEDDS的cmax和AUC显著高于溶液剂,tmax<溶液剂,生物利用度分别为333.9%和719.3%。结论:紫杉醇S-SMEDDS的口服吸收强于溶液剂和SMEDDS。 Objective: To prepare paclitaxol supersaturable self-microemulsifying drug delivery system(S-SMEDDS) and study its pharmacokinetics in rats.Methods: Pseudoternary phase diagrams were applied to optimize the formulation of S-SMEDDS.Eighteen rats were randomly divided into 3 groups and 10 mg/kg paclitaxel solution preparation was given by gavage,SMEDDS and S-SMEDDS,respectively.The plasma concentration of paclitaxel was determined by HPLC method.AUC,cmax and tmax were determined and relative bioavailability was calculated.Results: The optimal formulation of SMEDDS consisted of oil phase∶surfactants∶cosurfactant=50∶33∶17.Lauroglycol FCC-olive oil(2∶1) were used as oil phase,cremophor EL∶tween-80(1∶1)were used as surfactants and PEG-400 was used as cosurfactant.Oil phase of S-SMEDDS was obtained by adding 5% hydroxyl-propyl methyl cellulose(HPMC).Dilution had no significant effects on the particle size of SMEDDS and S-SMEDDS.The grain sizes of SMEDDS and S-SMEDDS were(92.7±47.7) and(93.6±36.8) nm with a Gaussian distribution.The cmax and AUC of SMEDDS and S-SMEDDS were higher than those of solution preparation,while tmax of SMEDDS and S-SMEDDS were lower.Relative bioavailabilities of SMEDDS and S-SMEDDS were 333.9% and 719.3%,respectively.Conclusion: S-SMEDDS significantly enhances the absorption and bioavailability of paclitaxel compared with solution preparation and SMEDDS.
出处 《药学服务与研究》 CAS CSCD 2011年第2期138-140,共3页 Pharmaceutical Care and Research
基金 上海市卫生局青年基金项目(No.2008Y023)
关键词 紫杉醇 自微乳化给药系统 超饱和自微乳化给药系统 药代动力学 生物利用度 paclitaxel self-microemulsifying drug delivery system supersaturatable self-microemulsifying drug delivery system pharmacokinetics bioavailability
  • 相关文献

参考文献5

  • 1Cheon Lee S,Kim C,Chan Kwon I,et al.Polymeric micelles of poly (2-ethyl-2-oxazoline)-block-poly (epsilon-caprolactone)copolymer as a carrier for paclitaxel[J].J Control Release,2003,89(3),437-446.
  • 2Izquierdo M A,Scheffer G L,Flens M] ,et al.Major vault protein LRP-related multidrug resistance[J].Eur J Cancer.1996.32A(6):979-984.
  • 3Pouton C W.Formulation of self-emulsifying drug delivery systems[J].Adv Drug Deliv Rev,1997,25(1),47-58.
  • 4Usui F,Maeda K,Kusai A,et al.Inhibitory effects of watersoluble polymers on precipitation of RS-8359[J].Int J Pharm,1997,154(1):,59-66.
  • 5Gao P,Akrami A,Alvarez F,et al.Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system(S-SEDDS) for improved oral absorption[J].J Pharm Sci,2009,98(2):516-528.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部